Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02353260Phase 2Unknown
Phase 2, randomised, open-label trial in head and neck squamous cell carcinoma (HNSCC) (2 arms). Primary endpoint: Rate of Disease Control at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02353260.